These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36083778)

  • 21. Copy number variation analysis of m
    Wang X; Yu J; Chen J; Hou Y; Du Z; Huang H; Tang S; Han Y; Ding C; Xue Z
    Cancer Med; 2021 Nov; 10(21):7804-7815. PubMed ID: 34668652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis.
    Tong L; Mitchel J; Chatlin K; Wang MD
    BMC Med Inform Decis Mak; 2020 Sep; 20(1):225. PubMed ID: 32933515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer.
    Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
    Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma.
    Liu C; Gao J; Yang D; Yu Q; Zhang S
    Front Pharmacol; 2022; 13():907433. PubMed ID: 35662721
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes.
    Wang L; Wang Y; Wang J; Li L; Bi J
    J Immunol Res; 2021; 2021():3236384. PubMed ID: 34708131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating multi-omics data by learning modality invariant representations for improved prediction of overall survival of cancer.
    Tong L; Wu H; Wang MD
    Methods; 2021 May; 189():74-85. PubMed ID: 32763377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options.
    Liu Z; Xu H; Weng S; Ren Y; Han X
    Front Immunol; 2022; 13():828330. PubMed ID: 35154148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a ten-long noncoding RNA signature for predicting the survival and immune status of patients with bladder urothelial carcinoma based on the GEO database: a superior machine learning model.
    Mao X; Chen S; Li G
    Aging (Albany NY); 2021 Feb; 13(5):6957-6981. PubMed ID: 33621953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.
    Guo Y; Yin J; Dai Y; Guan Y; Chen P; Chen Y; Huang C; Lu YJ; Zhang L; Song D
    Front Cell Dev Biol; 2021; 9():642650. PubMed ID: 34540821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer.
    Riester M; Taylor JM; Feifer A; Koppie T; Rosenberg JE; Downey RJ; Bochner BH; Michor F
    Clin Cancer Res; 2012 Mar; 18(5):1323-33. PubMed ID: 22228636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scoring System Based on RNA Modification Writer-Related Genes to Predict Overall Survival and Therapeutic Response in Bladder Cancer.
    Zhang P; Liu Z; Wang D; Li Y; Xing Y; Xiao Y
    Front Immunol; 2021; 12():724541. PubMed ID: 34512654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of an Autophagy-Immune Related Genes Score Signature and Prognostic Model and its Correlation with Immune Response for Bladder Cancer.
    Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
    Cancer Manag Res; 2022; 14():67-88. PubMed ID: 35023971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
    Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L
    Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma.
    Zhang F; Liang J; Feng D; Liu S; Wu J; Tang Y; Liu Z; Lu Y; Wang X; Wei X
    Front Cell Dev Biol; 2022; 10():814735. PubMed ID: 35281080
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomes.
    Burgess EF; Sanders JA; Livasy C; Symanowski J; Gatalica Z; Steuerwald NM; Arguello D; Brouwer CR; Korn WM; Grigg CM; Zhu J; Matulay JT; Clark PE; Heath EI; Raghavan D
    Urol Oncol; 2022 Aug; 40(8):383.e1-383.e10. PubMed ID: 35662501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in bladder urothelial carcinoma.
    Zhang C; Shen L; Qi F; Wang J; Luo J
    J Cell Physiol; 2020 Apr; 235(4):3849-3863. PubMed ID: 31596511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system.
    Li Z; Jiang L; Zhang Z; Deng M; Wei W; Tang H; Guo S; Ye Y; Yao K; Liu Z; Zhou F
    Cancer Med; 2022 Jan; 11(2):539-552. PubMed ID: 34816620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A hypoxia related long non-coding RNA signature could accurately predict survival outcomes in patients with bladder cancer.
    Zhang F; Wang X; Hu H; Yang Y; Wang J; Tang Y; Li D; Bai Y; Han P
    Bioengineered; 2021 Dec; 12(1):3802-3823. PubMed ID: 34281486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer.
    Iyer G; Al-Ahmadie H; Schultz N; Hanrahan AJ; Ostrovnaya I; Balar AV; Kim PH; Lin O; Weinhold N; Sander C; Zabor EC; Janakiraman M; Garcia-Grossman IR; Heguy A; Viale A; Bochner BH; Reuter VE; Bajorin DF; Milowsky MI; Taylor BS; Solit DB
    J Clin Oncol; 2013 Sep; 31(25):3133-40. PubMed ID: 23897969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival.
    Chen Z; Liu G; Hossain A; Danilova IG; Bolkov MA; Liu G; Tuzankina IA; Tan W
    Hereditas; 2019; 156():24. PubMed ID: 31333338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.